KnowTheStock
Log inCreate free account

CVS Health Corp

CVS
S&P 500NEW YORK STOCK EXCHANGE INC.
$103.58last close · market cap 133.31 Billion
Compare with…
32.5SCORE / 100
Our verdictSELLWeak Growth, Stock Price Very HighQtr Ending 2026-06-30 · trend negative

Why Sell

Cash flow is moderate; income statement and balance sheet are weak.

Next earnings: 2026-11-04 (BMO), EPS Forecast: $1.62

What is strong
  • Total Debt to Total Assets Ratio is 0.24
  • Cash from Operations Growth is 95.3%
What to watch
  • Revenue Growth is 7.36%
  • Operating Income Growth is -7.45%
  • Net Income Growth is 7.92%
  • Earnings Per Share (EPS) Growth is 5.85%
  • Net Margin is 1.18%
  • Current Asset to Current Liability Ratio is 0.87
  • Debt Ratio is 0.69
  • Current Debt to Net Income Ratio is 0.66
  • Capital Expenditure is High
  • Net Increase in Cash is Negative
  • Investment Risk is High

What changed

Score by quarter

Downgraded from Hold to Sell in the Sep 2024 quarter: 44.2 → 37.7 (-6.5). This quarter: +2.1.

304050Sep 2022Jun 2026

What the score is made of

Income statement35.5 +3.8
Balance sheet19.0 +0.0
Cash flow47.2 +0.0

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)415.09 Billion7.36 % growth
EPS3.805.85 % growth
Profit margin1.18 %Profit per $1 of sales
P-E ratio—Not available
Market cap133.31 BillionShares × price
Debt-equity ratio0.77Leverage
Dividend2.66Per share, annual
Next earnings2026-11-04BMO · EPS forecast $1.62
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About CVS Health Corp

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands.

CEO
Larry Merlo
Employees
219,000
Exchange
NEW YORK STOCK EXCHANGE INC.
cvshealth.com

Similar stocks

Loading…